2-benzylglutarimide | 97938-45-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 2-benzylglutarimide
• 英文别名: 3-benzylpiperidine-2,6-dione；2-Benzylglutarimid；3-Benzyl-piperidin-2,6-dion
• CAS: 97938-45-9
• 化学式: C₁₂H₁₃NO₂
• 分子量: 203.241
• InChiKey: YMEUOMXAEBYIPR-UHFFFAOYSA-N

物化性质

• 熔点：
  142-144 °C(Solv: ethanol (64-17-5))
• 沸点：
  392.4±11.0 °C(Predicted)
• 密度：
  1.169±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  46.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-benzylglutarimide 在 盐酸 作用下， 生成 benzylglutaric acid
  参考文献：
  名称：

  Dianions derived from glutarimide, 3,5-morpholinedione, and 3,5-thiomorpholinedione as useful new synthetic intermediates

  摘要：

  DOI：

  10.1021/jo00836a003
• 作为产物：
  描述：

  2-苄基乙酰乙酸乙酯 在 氢氧化钾 、 sodium ethanolate 作用下， 生成 2-benzylglutarimide
  参考文献：
  名称：

  Yue et al., Huaxue Xuebao/Acta Chimica Sinica, 1959, vol. 25, p. 146,147

  摘要：

  DOI：

文献信息

• Synthesis of Succinimido[3,4-b]indane and 1,2,3,4,5,6-Hexahydro-1,5-methano-3-benzazocine-2,4-dione by Sequential Alkylation and Intramolecular Arylation of Enolates Derived from <i>N,N,N</i><i>‘</i><i>N</i>‘-Tetramethylbutanediamides and <i>N,N,N</i><i>‘</i><i>N</i>‘-Tetramethylpentanediamides
  作者：Sushama A. Dandekar、Stacey N. Greenwood、Thomas D. Greenwood、Stéphane Mabic、Joseph S. Merola、James M. Tanko、James F. Wolfe

  DOI：10.1021/jo982000b

  日期：1999.3.1

  refluxing THF. Treatment of 20 with KNH(2) in liquid NH(3) led to intramolecular arylation and accompanying ammonolysis to afford trans-1-(N,N-dimethylcarboxamido)-1,2,3,4-tetrahydronaphthalene-3-carboxamide (21b). Conversion of 21b to 5 was similarly effected by means of NaH. Experiments designed to test the mechanistic aspects of the intramolecular arylations provided evidence for competing aryne and SET

  通过将N，N，N'，N'-四甲基丁二酰胺（6）和N，N，N'，N'-四甲基戊二酰胺（19）的单烯酸锂初始烷基化来合成三环标题化合物4和5于-60°C在液体NH（3）中生成-碘代苄基氯，得到2-（2-碘代苄基）-N，N，N'，N'-四甲基丁二酰胺（9）和2-（2-碘代苄基）-N，N ，N′，N′-四甲基戊二酰胺（20）的产率分别为88％和87％。在液体NH（3）中用KNH（2）处理9导致形成和分子内芳基化的程度较低，即取代的α-烯酸酯在60中产生反式1,2-双（N，N-二甲基甲酰胺基）茚满（10a） ％ 让。用Na（2）O（2）水溶液选择性水解10a，得到反式1-（N，N-二甲基羧酰胺基）茚满-2-羧酸（17），然后通过转化为反式-1-（N，N-二甲基羧酰胺基）茚满-2-羧酰胺（10c）将其转化为桥接的琥珀酰亚胺4，然后通过NaH在回流的THF中将该混合的伯/叔酰胺环化。用液体NH（3）中的
• [EN] C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION<br/>[FR] DÉGRONIMÈRES DE TYPE GLUTARIMIDE LIÉS AU CARBONE C3 POUR LA DÉGRADATION DE PROTÉINES CIBLES
  申请人：C4 THERAPEUTICS INC

  公开号：WO2017197046A1

  公开（公告）日：2017-11-16

  This invention provides Degronimers that have carbon-linked E3 Ubiquitin Ligase targeting moieties (Degrons), which can be linked to a targeting ligand for a protein that has been selected for in vivo degradation, and methods of use and compositions thereof as well as methods for their preparation.

  这项发明提供了一种Degronimers，它具有碳连接的E3泛素连接酶靶向基团（Degrons），可以与一个靶向配体相连，该配体针对的是在体内被选为降解的蛋白质，以及它们的使用方法和组成，以及它们的制备方法。
• C3-carbon linked glutarimide degronimers for target protein degradation
  申请人：C4 Therapeutics, Inc.

  公开号：US10849982B2

  公开（公告）日：2020-12-01

  This invention provides Degronimers that have carbon-linked E3 Ubiquitin Ligase targeting moieties (Degrons), which can be linked to a targeting ligand for a protein that has been selected for in vivo degradation, and methods of use and compositions thereof as well as methods for their preparation.

  本发明提供了具有碳连接的 E3 泛素连接酶靶向分子（Degronimers）的 Degronimers（Degronons），这些 Degronimers 可与用于体内降解的蛋白质的靶向配体连接，本发明还提供了其使用方法和组合物及其制备方法。
• Synthesis and anticonvulsant activity of 2-benzylglutarimides
  作者：R. Richard Goehring、Thomas D. Greenwood、Godson C. Nwokogu、Jyothi S. Pisipati、Tommie G. Rogers、James F. Wolfe

  DOI：10.1021/jm00165a007

  日期：1990.3

  A series of 2-benzylglutarimides (4) and their N-methyl analogues (5) were prepared according to the Topliss scheme for the selection of benzyl substituents to maximize anticonvulsant activity. A total of 22 such compounds were subjected to initial (phase I) screening in mice against seizures induced by maximal electroshock (MES) and pentylenetetrazol (scMet) and in the rotorod assay for neurotoxicity. From this series of test compounds, 10 were advanced to quantitative (phase II) testing. Of these, 2-(4-chlorobenzyl)glutarimide (4b) emerged as the most promising anticonvulsant drug candidate by demonstrating both good anti-scMet and anti-MES activity combined with low neurotoxicity after intraperitoneal administration in mice. In drug differentiation tests, 4b was also effective in nontoxic doses against seizures induced by bicuculline, picrotoxin, and strychnine. When compared with the clinically useful drugs phenytoin, carbamazepine, phenobarbital, valproate, and ethosuximide, 4b exhibited an overall pharmacological profile most closely resembling that of valproate.
• GOEHRING, R. RICHARD;GREENWOOD, THOMAS D.;NWOKOGU, GODSON C.;PISIPATI, JU+, J. MED. CHEM., 33,(1990) N, C. 926-931
  作者：GOEHRING, R. RICHARD、GREENWOOD, THOMAS D.、NWOKOGU, GODSON C.、PISIPATI, JU+

  DOI：——

  日期：——